Cite

HARVARD Citation

    Xu, Y. et al. (2022). Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer. Journal of immunology research. p. . [Online]. 
  
Back to record